Researchers found protein tyrosine phosphatase nonreceptor type 2 (PTPN2) expression was downregulated in pancreatic ductal adenocarcinoma (PDAC) tissues, and decreased PTPN2 expression was associated with unfavorable prognosis.
[Molecular Carcinogenesis]
